Indication

Small cell lung carcinoma

Small cell lung carcinoma is an aggressive, high-grade neuroendocrine malignancy that originates primarily in the respiratory epithelium of the bronchial tree. Read more about Small cell lung carcinoma

87 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Small cell lung carcinoma therapies.

Showing 1–9 of 87 drugs

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Parke-Davis Pfizer

ETOPOSIDE

ANTINEOPLASTIC - EPIPODOPHYLLOTOXINS·SMALL CELL LUNG CARCINOMA
Mylan Pharmaceuticals

CISPLATIN

OVARIAN GERM CELL TUMOR CARCINOMA·+5
APP PHARMACEUTI
Filter & compare in the drug finder →Opens the drug finder with Small cell lung carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Small cell lung carcinoma.

Small cell lung carcinoma is an aggressive, high-grade neuroendocrine malignancy that originates primarily in the respiratory epithelium of the bronchial tree.

It predominantly affects adults with a heavy history of tobacco exposure, accounting for approximately 15% of all pulmonary malignancies.

Pathophysiologically, it is defined by near-universal functional inactivation of tumor suppressor genes TP53 and RB1, rapid tumor doubling time, high mitotic activity, and widespread neuroendocrine differentiation.

Histologically and clinically, it is characterized by sheets of small, poorly differentiated cells with scant cytoplasm, granular nuclear chromatin, extensive necrosis, and a marked propensity for early hematogenous dissemination and paraneoplastic manifestations.

Personalize your experience

Follow Small cell lung carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it